AlphaQuest LLC Acquires 1,468 Shares of ICU Medical, Inc. $ICUI

AlphaQuest LLC boosted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 3,058.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,516 shares of the medical instruments supplier’s stock after buying an additional 1,468 shares during the quarter. AlphaQuest LLC’s holdings in ICU Medical were worth $200,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the business. Ameriprise Financial Inc. raised its holdings in ICU Medical by 18.5% in the 1st quarter. Ameriprise Financial Inc. now owns 693,711 shares of the medical instruments supplier’s stock valued at $96,326,000 after buying an additional 108,493 shares during the last quarter. William Blair Investment Management LLC bought a new position in ICU Medical in the 2nd quarter valued at approximately $27,928,000. Invesco Ltd. raised its holdings in ICU Medical by 80.1% in the 1st quarter. Invesco Ltd. now owns 203,827 shares of the medical instruments supplier’s stock valued at $28,303,000 after buying an additional 90,674 shares during the last quarter. Woodline Partners LP raised its holdings in ICU Medical by 31.6% in the 1st quarter. Woodline Partners LP now owns 160,910 shares of the medical instruments supplier’s stock valued at $22,344,000 after buying an additional 38,671 shares during the last quarter. Finally, Victory Capital Management Inc. raised its holdings in ICU Medical by 5.7% in the 1st quarter. Victory Capital Management Inc. now owns 149,246 shares of the medical instruments supplier’s stock valued at $20,724,000 after buying an additional 8,101 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, Director David C. Greenberg purchased 1,200 shares of ICU Medical stock in a transaction that occurred on Wednesday, August 27th. The stock was acquired at an average price of $126.42 per share, with a total value of $151,704.00. Following the transaction, the director owned 7,960 shares in the company, valued at $1,006,303.20. This trade represents a 17.75% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Vivek Jain acquired 21,929 shares of the company’s stock in a transaction on Thursday, August 14th. The stock was acquired at an average cost of $112.84 per share, for a total transaction of $2,474,468.36. Following the completion of the purchase, the chief executive officer directly owned 130,149 shares of the company’s stock, valued at approximately $14,686,013.16. This represents a 20.26% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ICUI. Weiss Ratings reiterated a “sell (d-)” rating on shares of ICU Medical in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Friday, September 5th. KeyCorp reduced their price objective on shares of ICU Medical from $191.00 to $173.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 21st. Piper Sandler upped their price objective on shares of ICU Medical from $145.00 to $153.00 and gave the company an “overweight” rating in a research note on Wednesday, September 10th. Finally, Raymond James Financial reduced their price objective on shares of ICU Medical from $187.00 to $180.00 and set a “strong-buy” rating on the stock in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $176.50.

ICU Medical Stock Performance

NASDAQ:ICUI opened at $120.09 on Monday. The company has a fifty day moving average of $123.87 and a 200-day moving average of $128.39. The firm has a market capitalization of $2.96 billion, a P/E ratio of -79.01 and a beta of 0.83. The company has a quick ratio of 1.17, a current ratio of 2.44 and a debt-to-equity ratio of 0.63. ICU Medical, Inc. has a twelve month low of $107.00 and a twelve month high of $196.26.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.66. The company had revenue of $543.57 million during the quarter, compared to analyst estimates of $543.33 million. ICU Medical had a negative net margin of 1.56% and a positive return on equity of 7.24%. ICU Medical’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.56 EPS. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. As a group, sell-side analysts anticipate that ICU Medical, Inc. will post 4.11 EPS for the current year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.